A healthcare professional administers an injection of the Moderna COVID-19 vaccine at a vaccination centre at Ffwrnes Theatre in Llanelli, South Wales, on April 9, 2021. JOHANNESBURG - New pre-screening measures will be in place when the Sisonke Johnson & Johnson vaccine trial resumes on Wednesday. The trial was put on hold two weeks ago after six cases of rare blood clots were reported in the United States. This prompted government to do further studies. READ: COVID-19 in SA | J&J vaccine rollout to resume To date, 300,000 healthcare workers have been vaccinated as part of the trial. More than 200,000 are still waiting for their jabs. Bhekisisa Editor-In-Chief, Mia Malan explains the new pre-screening measures in the video below.